Feedback / Questions
hydrogen sulfide-releasing derivative of ketoprofen (ATB-352) - Antibe
hydrogen sulphide-releasing derivative of naproxen (ATB-346) - Antibe
https://www.businesswire.com/news/home/20200609005782/en/Antibe-Therapeutics-Announces-25-Million-Bought-Deal
Jun 9, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next